Conference Call with Dr. Lal Pathlabs Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal Pathlabs announced Q4FY25 results Revenue: Rs 603 crore compared to Rs 545 crore during Q4FY24, change 10.5%. EBITDA: Rs 169 crore compared to Rs 145 crore during Q4FY24, change 16.9%. EBITDA margin: 28.1% for Q4FY25. PAT: Rs 156 crore compared to Rs 86 crore during Q4FY24, change 81.4%. PAT margin: 25.8% for Q4FY25. Fourth Interim Dividend of Rs 6 per share for FY25. Result PDF